CLB Core Laboratories Inc

  1. Stocks
  2. Energy
  3. NYSE: CLB

Price (delayed)

$10.505

Market cap

$482.02M

P/E Ratio

19.82

Dividend/share

$0.04

EPS

$0.53

Enterprise value

$624.4M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 43

Core Laboratories N.V. (Core Lab) is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. These products and services are directed toward ...

Highlights
The stock's price to earnings (P/E) is 49% less than its 5-year quarterly average of 39.6 and 12% less than its last 4 quarters average of 22.7
CLB's debt is down by 8% YoY
The quick ratio has decreased by 6% YoY but it has increased by 4% QoQ
Core Laboratories's EPS has decreased by 18% YoY and by 16% from the previous quarter
CLB's net income is down by 18% year-on-year and by 16% since the previous quarter
Sector: Energy
Industry: Oil & Gas Equipment & Services
Website: http://www.corelab.com
Peers: OII SLB FISV HAL

Key stats

What are the main financial stats of CLB

CLB stock price

How has the Core Laboratories stock price performed over time
Intraday
-1.18%
1 week
-7.85%
1 month
-12.82%
1 year
-15.89%
YTD
-34.47%
QTD
-9.83%

Financial performance

How have Core Laboratories's revenue and profit performed over time
Revenue
$519.18M
Gross profit
$101.32M
Operating income
$47.8M
Net income
$24.35M
Gross margin
19.5%
Net margin
4.7%
CLB's net margin is down by 18% YoY and by 15% from the previous quarter
CLB's net income is down by 18% year-on-year and by 16% since the previous quarter
The operating margin has decreased by 12% YoY and by 11% from the previous quarter
Core Laboratories's operating income has decreased by 11% QoQ and by 11% YoY

Price vs fundamentals

How does CLB's price correlate with its fundamentals

Growth

What is Core Laboratories's growth rate over time

Valuation

What is Core Laboratories stock price valuation
CLB P/E details
P/E
19.82
P/B
1.78
P/S
0.93
EV/EBIT
13.16
EV/EBITDA
10.02
EV/Sales
1.2
The stock's price to earnings (P/E) is 49% less than its 5-year quarterly average of 39.6 and 12% less than its last 4 quarters average of 22.7
Core Laboratories's EPS has decreased by 18% YoY and by 16% from the previous quarter
The P/B is 58% below the 5-year quarterly average of 4.3 and 28% below the last 4 quarters average of 2.5
CLB's equity is up by 4.4% YoY
CLB's price to sales (P/S) is 48% lower than its 5-year quarterly average of 1.8 and 28% lower than its last 4 quarters average of 1.3

Efficiency

How efficient is Core Laboratories business performance
The return on equity has declined by 23% year-on-year and by 17% since the previous quarter
The ROA has contracted by 18% YoY and by 16% from the previous quarter
Core Laboratories's ROS has decreased by 12% YoY and by 11% from the previous quarter
The return on invested capital has declined by 10% since the previous quarter and by 5% year-on-year

Dividends

What is CLB's dividend history
Dividend details
DPS
$0.04
Dividend yield
0.38%
Payout ratio
7.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Core Laboratories financials performed over time
The total assets is 91% greater than the total liabilities
The total liabilities has decreased by 8% YoY
CLB's current ratio is down by 7% year-on-year but it is up by 3.4% since the previous quarter
CLB's debt is 39% less than its equity
The debt to equity has decreased by 10% YoY
CLB's debt is down by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.